Helicobacter Pylori and Gi Tract Disease

You might also like

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 15

HELICOBACTER PYLORI AND GI TRACT DISEASE:

PATHOGENESIS, SYMPTOMS, DIAGNOSIS, TREATMENT


AND PREVENTION
PRESENTED BY
AKINGBADE KEHINDE ABDULAZEEZ
MCB/2016/065

SEMINAR SUPERVISOR
DR. (MRS.) C.D. FASHINA

SEMINAR COORDINATOR
DR. O.O. OMOBOYE 1
OUTLINE OF THIS PRESENTATION

• INTRODUCTION—MORPHOLOGY AND STRUCTURE OF Helicobacter pylori

• PATHOGENESIS OF Helicobacter pylori INFECTION

• EPIDEMIOLOGY

• SYMPTOMS AND CLINICAL MANIFESTATIONS OF Helicobacter pylori


INFECTION

• DIAGNOSIS OF Helicobacter pylori infection

• PREVENTION AND TREATMENT OF Helicobacter pylori INFECTION

• CONCLUSION
2
INTRODUCTION—MORPHOLOGY AND
STRUCTURE OF Helicobacter pylori

• Helicobacter pylori is a spiral Gram-


negative bacteria
• It has a multiple polar flagella above the
pole and motile
• Thrives in the stomach acid
• Not cleared by host immune response
• Breaks down urea to ammonia and
carbondioxide
• Produces adhesins which aids its
binding to epithelial cells
3
PATHOGENESIS AND PATHOLOGY
• Helicobacter pylori is found in the deep mucus layer

• Spread by oral-oral contact

• Faeco-oral spread prominent

• Causes mild to acute gastritis

• Poverty and overcrowding predisposes

• Its motility enables it to thrive in mucus and the epithelial surface of the GI tract

• Colonizes mucosa but does not involve mucosa

4
FACTORS AFFECTING THE PATHOGENICITY OF H.pylori

• Lipopolysaccharides—damage mucosal cells and Ammonia produced


by Urease activity may directly damage cells

• Gastritis—Chronic inflammation of the epithelial lining of the GI tract

• Events leading to the destruction of the epithelium is common


(Carraher et al., 2015)

• Glandular atrophy is common

5
.

6
EPIDEMIOLOGY

• H. pylori infection occurs worldwide


• Prevalence varies greatly among
countries and population groups
• 20-50% prevalence rate among adults
in industrialised countries (Didelot et
al., 2017)
• >80% prevalence rate in middle age
adults in developing countries (may
reflect poorer living conditions)

7
Areas where Helicobacter pylori infection can be found in
the GI tract (Yu et al., 2014)

8
SYMPTOMS AND SYMPTOMS OF Helicobacter
pylori INFECTION
• Upper Gastrointestinal illness
• Nausea
• Pain
• Fever—very occasionally
• Loss of appetite
• Unintentional weight loss (Didelot et
al., 2017)
• Acute symptoms lasts for < 1 week
• H. pylori infection may last for years,
decades or even lifetime
9
DIAGNOSIS OF Helicobacter pylori INFECTION

INVASIVE NON-INVASIVE
Histopathology Urea Breath Test
Rapid Urease Test Stool Ag
Culture Serology
PCR

10
TREATMENT AND PREVENTION OF
Helicobacter pylori INFECTION
TREATMENT
• Use of drugs to reduce gastric acidity as well as antibiotics
• Proton Pump Inhibitors, Histamine blockers, Pepto-Bismol can
suppress gastric acidity
• Antibiotics like Amoxillin, Metronidazole, Levofloxacin, Tetracycline
are recommended however with strict medical supervision (Carraher et
al., 2015)

11
TREATMENT AND PREVENTION OF
Helicobacter pylori INFECTION
PREVENTION
• There is no vaccine for H. pylori
• Avoid unsanitary areas
• Wash your hands thoroughly
• Get tested
• Adequate nutrition
• Avoid poorly cooked foods
• Improvement of public health standards

12
CONCLUSION

Data from recent studies show that the prevalence of H. pylori infection
is still high in most countries worldwide. H. pylori is a common and
significant human pathogen central to the pathogenesis of many
gastroduodenal disorders. Thus, understanding the pathogenesis of the
infection is central to effective prevention strategies

13
REFERENCES
• Adlekha S, Chadha T, Krishnan P, Sumangala B (2013). Prevalence of
Helicobacter pylori infection among patients undergoing upper gastrointestinal
endoscopy in a medical college hospital in kerala, India. Ann Med Health Sci Res
2013;3:559–63.
• Carraher S, Chang HJ, Munday R, Goodman K.J (2015). Helicobacter pylori
incidence and re-infection in the Aklavik H. pylori Project. Int J Circumpolar
Health 2015;72:1–7.
• Didelot X, Nell S, Yang I, Woltemate S, van der Merwe S, Suerbaum S (2017).
Genomic evolution and transmission of Helicobacter pylori in two South African
families. Proc Natl Acad Sci U S A 2017;110:13880–5.
• Yu Y, Su L, Wang X, Wang X, Xu C (2014). Association between Helicobacter
pylori infection and pathological changes in the gastric mucosa in Chinese
children. Intern Med 2014;53:83–8.
14
.

15

You might also like